Pathology News

Join Pathology News for this short interview, where Sidney Ocanagil-Tunstall speaks with Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS Trust, and Steven Lynum, President and CEO of Epredia, about Tango - a new technology designed to tackle stain variability and support greater consistency across histopathology laboratories.In the conversation, David and Steven explore the story behind Tango, its development through a collaboration between Leeds and Epredia, and how improving upstream staining consistency could help create higher-quality, more standardised data for digital pathology and AI.Looking ahead, the discussion considers Tango’s potential to support AI readiness by reducing variability, making algorithms easier to develop and deploy, and helping move AI towards more scalable use in routine pathology workflows.

wing the recent partnership between Leica Biosystems and DiaDeep, join us for this short Pathology News interview, where Sidney Ocanagil-Tunstall speaks with Bryce Brown, Director of Product Enablement at Leica Biosystems, about what the collaboration means for AI adoption in digital pathology. In the conversation, Bryce explores how DiaDeep’s biomarker quantification tools are being integrated into the Aperio AI Store, helping laboratories access specialised AI applications through a single digital pathology workflow. He also discusses the Store’s flexible approach to licensing and its growing ecosystem of AI partners. Looking ahead, the discussion considers how Leica Biosystems is working to move AI beyond proof-of-concept and into practical, routine pathology workflows, with a focus on accessibility, integration and supporting pathologists as AI adoption continues to grow.

In this episode, Sidney Ocanagil-Tunstall is joined by Dr Adam Shephard, Assistant Professor at the University of Warwick's Tissue Image Analytics (TIA) Centre, and Dr Hanya Mahmood, Senior Clinical Lecturer and Honorary Consultant Oral Surgeon at the University of Sheffield, to explore how artificial intelligence is transforming the diagnosis and management of oral epithelial dysplasia (OED).The conversation focuses on OYDN, an AI-powered computational pathology model developed through a collaboration between the TIA Centre and the University of Sheffield. Adam and Hanya discuss how the technology supports more objective diagnosis, improves risk stratification for patients at risk of developing oral cancer, and is helping uncover novel digital biomarkers that could shape future treatment strategies.The discussion broadens into the challenges of translating AI from research into routine clinical practice, exploring the importance of explainable AI, robust validation, clinician confidence, and NHS adoption. Looking ahead, the guests share their vision for how AI can support pathologists, standardise clinical decision-making, and ultimately improve outcomes for patients through earlier, more accurate intervention.

In this episode, Sidney Ocanagil-Tunstall continues the conversation with Dr Julia Jones, Elsa Santos and Cara Brodie from the Cancer Research UK Cambridge Institute, focusing on the technologies underpinning modern digital pathology workflows.The discussion explores how the team evaluates and procures whole slide scanners, balancing image quality, flexibility and downstream compatibility over speed alone. They also examine the growing importance of colour standardisation across scanning platforms, the challenges it presents for image analysis, and how AI could help overcome variability to deliver more robust and reproducible results.Looking ahead, the conversation turns to the future of multimodal imaging, data integration and artificial intelligence, alongside practical advice for researchers adopting new technologies in digital pathology and spatial biology.

In this episode, Sidney Ocanagil-Tunstall visits the Cancer Research UK Cambridge Institute to explore how digital pathology and spatial biology are transforming cancer research.Joined by Dr Julia Jones, Scientific Manager for In Situ Hybridisation, alongside Senior Scientific Associates Elsa Santos and Cara Brodie, the conversation examines the Institute’s long-standing commitment to innovation, from early adoption of digital pathology workflows to the integration of advanced spatial omics technologies.The discussion covers image analysis, multiplex assays, multimodal approaches combining RNA and protein detection, and the growing role of spatial biology in understanding the tumour microenvironment. The team also reflects on the practical challenges of implementation, including costs, technology selection, collaboration, and the importance of shared expertise in driving the next generation of cancer research.

In this episode, Sidney Ocanagil-Tunstall continues the conversation with Dr Asif Naseem, GP and specialist in preventative healthcare and men's health, and Dr Beat Rheiner, CEO of Proteomedix, this time turning to what a better diagnostic pathway could actually look like in practice.Building on the challenges of PSA testing explored in Episode 1, the discussion moves into the role of emerging tools like Proclarix in supporting smarter clinical decision-making. Asif shares his real-world experience using Proclarix as a private GP, including how it has helped him identify patients who may benefit from further investigation, and those who can safely avoid unnecessary downstream procedures.The conversation broadens into a wider discussion around diagnostics implementation and adoption,  exploring the relationship between laboratory and clinician as part of the same clinical decision-making process, and why awareness of such diagnostic tools remains one of the most important barriers to overcome. As Asif puts it: new tools need to be more accessible, more widely understood, and correctly used.Proclarix is a blood-based test which works in the PSA "grey zone" of 2-10ng/ML to better stratify risk of clinically significant prostate cancer.

In this episode, Sidney Ocanagil-Tunstall is joined by Dr Asif Naseem, GP and specialist in preventative healthcare and men's health, alongside Dr Beat Rheiner, CEO of Proteomedix. Together, they discuss the role of PSA testing in current prostate cancer pathways, why many patients fall into a diagnostic “gray zone,” and how emerging approaches could improve early detection and reduce uncertainty for both clinicians and patients.The conversation explores the importance of personalised risk assessment, the impact of false positives and false negatives, and how new diagnostic tools may help identify clinically significant cancers earlier while supporting more efficient, patient-centred care. 

In this Thought Leaders episode, Sidney Ocanagil-Tunstall speaks with Dr. Tiffany Chen, Chief Medical Officer at Techcyte, about the realities of digital pathology adoption and what pathologists truly need from technology. The conversation explores workflow integration, AI in routine practice, trust in digital systems, and how Techcyte’s Fusion AP platform is designed to simplify increasingly complex pathology environments. Together, they discuss the future of pathology, where seamless workflows, interoperability, and pathologist-centred design are key to successful digital transformation.

In this episode of the Pathology News podcast, Sidney Ocanagil-Tunstall speaks with Eric Walk about how AI-powered pathology tools are beginning to transform clinical diagnostics, pathology workflows, and precision medicine infrastructure.Eric discusses where AI is already delivering value in clinical practice, including case triage, workload balancing, biomarker quantification, quality control, and pathology workflow optimisation through PathAI’s AI Site DX platform. The conversation also explores the growing importance of trust, validation, and human oversight in AI-assisted diagnostics, alongside the ethical questions surrounding patient confidence and clinical decision-making.The episode further examines PathAI’s Precision Pathology Network (PPN), including how digitally mature pathology laboratories can collaborate with pharmaceutical companies through clinical trials, companion diagnostics, data licensing, and biomarker discovery programs. Rather than replacing pathologists, the discussion highlights how deep neural networks may elevate the profession, allowing pathologists to focus less on repetitive measurement tasks and more on precision medicine, therapy guidance, and integrated patient care. 

Sidney Ocanagil-Tunstall, Marketing Director at Pathology News, returns for part 4 of the Pathology Bites series joined by ESDIP leaders Norman Zerbe, Vincenzo L’Imperio, and Inti Zlobec to explore the future of pathology and how professionals can become involved with the organisation and its growing international community.The discussion looks ahead at the next phase of digital and computational pathology, from the wider adoption of digital workflows and AI-powered biomarkers to the growing role of computational tools in therapeutic guidance and patient care. The panel also reflects on the importance of harmonisation, interdisciplinary collaboration, and real-world clinical implementation as the field continues to evolve.Alongside the future-facing conversation, the episode highlights how ESDIP is supporting the pathology community through education, global partnerships, accessible membership opportunities, and initiatives such as the ESDIP Academy. From residents and researchers to practicing pathologists and industry leaders, the discussion captures how the society is helping shape the future of pathology while creating opportunities for the next generation to get involved. 

In this episode of the Pathology News podcast, Sidney Ocanagil-Tunstall speaks with Eric Walk about the evolving role of deep neural networks in digital pathology and how AI-assisted tools are beginning to reshape clinical diagnostics and drug development.Eric reflects on his career journey from diagnostic pathology into precision medicine and biomarker innovation, before exploring how AI is currently being deployed across pathology workflows, clinical trials, and translational research. The conversation covers digital transformation in pathology, workflow efficiency, predictive biomarkers, variability in clinical trials, and the growing role of AI-assisted decision support.The episode also explores PathAI’s work in MASH and inflammatory bowel disease, including FDA and EMA-qualified AI assist tools designed to improve biomarker scoring and endpoint assessment. Rather than focusing solely on diagnosis, the discussion highlights how computational pathology is enabling more structured histopathology data, improving reproducibility, and creating new opportunities for precision medicine and clinical research.

Sidney Ocanagil-Tunstall, Marketing Director at Pathology News, returns for another episode of Pathology Bites joined by leaders from the European Society of Digital and Integrated Pathology (ESDIP) – Norman Zerbe, Vincenzo L’Imperio, and Inti Zlobec – to explore how the society is building and supporting its growing global community beyond the annual congress.The discussion highlights ESDIP’s wider mission to connect, educate, and support professionals across digital and computational pathology through scientific publications, webinars, collaborative initiatives, and accessible membership opportunities. The panel reflects on the society’s work in producing practical guidance for digital pathology implementation, annotation standards, AI bias, computational pathology education, and understanding the EU AI Act, all designed to help laboratories and clinicians navigate an increasingly complex and rapidly evolving field.Alongside the scientific contributions, the episode explores how ESDIP is fostering engagement through monthly webinars, international collaborations, networking opportunities, and structured member involvement. From residents and technicians to experienced pathologists and researchers, the conversation captures how ESDIP is creating an inclusive and collaborative environment where members can contribute ideas, build connections, and help shape the future of digital pathology together.

This episode continues the conversation with Rahul, focusing on the practical realities of implementing digital pathology.Rahul explains why digitisation is not simply about replacing microscopes with scanners. Instead, it exposes wider laboratory challenges, from section quality and workflow design to IT infrastructure, LIMS–IMS integration, staffing, space, governance, and NHS data-sharing barriers.The discussion also explores the impact on day-to-day practice, including digital quality control, remote working, faster case sharing, and the transformation of MDT preparation. Rahul then reflects on the differences between pathology in the UK and India, before discussing AI bias, global datasets, and why broader representation will matter as algorithms enter clinical use.The episode closes with Rahul’s advice to young pathologists: see as much as possible, ask questions, and build strong relationships with clinical colleagues.

Sidney Ocanagil-Tunstall, Marketing Director at Pathology News, returns for episode 2 joined by leaders from the European Society of Digital and Integrated Pathology – Norman Zerbe, Vincenzo L'imperio, and Inti Zlobec – to explore what’s ahead for ECDP 2026 and the major themes shaping this year’s congress.The discussion highlights how ECDP is evolving beyond a traditional pathology meeting into a full “Digital and Computational Pathology Week”, with hands-on workshops, interoperability showcases, AI-focused sessions, and multidisciplinary collaboration at its core. The panel explores the growing role of integrative pathology across oncology, radiology, spatial biology, and computational diagnostics, while also reflecting on the importance of standardisation, education, and global community building.From practical implementation challenges to future-facing innovation, the episode captures how ECDP is creating a collaborative space where pathologists, researchers, technicians, clinicians, and industry leaders can connect, learn, and help shape the future of digital pathology together.

In this episode of the Pathology News podcast, Sidney Ocanagil-Tunstall speaks with Rahul Deb, Lead Breast and GI Pathologist at University Hospitals of Derby and Burton NHS Trust, about what it really takes to implement digital pathology in the NHS. Rahul reflects on his journey into pathology, from training in India to practising in the UK, before discussing Derby’s own digital transformation. The conversation covers whole slide imaging, speech-to-text reporting, validation, funding, training, and the practical challenges of moving from glass slides to digital workflows.Rahul also shares Derby’s approach to AI implementation in breast and prostate pathology, including the importance of clinical champions, staff engagement, and realistic business cases. Rather than presenting digitisation as a simple technology upgrade, the episode explores how digital pathology changes the way departments work, train, report, and prepare for the future of computational pathology.

In this Thought Leaders episode, Sydney Ocanagil-Tunstall, Marketing Director at Pathology News, speaks with leaders from the European Society of Digital and Integrated Pathology-Norman Zerbe, Vincenzo Imperiale, and Inti Zlobec-about the rapid evolution of digital pathology.The conversation explores how the field is moving beyond adoption toward effective integration with radiology, genomics, and wider oncology workflows. The panel also shares their personal journeys and reflects on key challenges, including interoperability, regulation, and workforce readiness.Beyond its annual congress, ESDIP is highlighted as a year-round community hub, offering initiatives like webinars, educational resources, and collaborative projects to support the global pathology community.The episode emphasises that the future of pathology depends not just on technology, but on multidisciplinary collaboration and a shared commitment to advancing digital, data-driven diagnostics.

In this Thought Leaders episode, Sidney Ocanagil-Tunstall, Marketing Director of Pathology News, speaks with Liron Pantanowitz, Chair of Pathology at the University of Pittsburgh and a pioneer in digital pathology and computational pathology.With a career spanning pathology informatics, whole slide imaging, and AI-driven diagnostics, Liron shares his journey from early frustrations with analogue workflows to becoming a global leader in digital transformation. He reflects on the origins of digital pathology, the development of validation guidelines with the College of American Pathologists, and how evidence-based practice has evolved over time.The conversation explores how UPMC is scaling digital pathology across a vast network of hospitals, building one of the most ambitious AI ecosystems in healthcare. Liron discusses the creation of the CPACE AI Center, the integration of imaging, text, and tabular data, and the growing role of both traditional and generative AI in clinical workflows.They also dive into real-world implementation challenges—from interoperability and vendor integration to cultural resistance among pathologists—and why mindset remains one of the biggest barriers to adoption. Liron shares insights into deploying AI in live clinical practice, the current lack of reimbursement models, and what the future may hold for billing, regulation, and global adoption.Finally, the episode highlights innovative initiatives like the “scan van” concept for mobile digitisation, the importance of building digital archives, and why laboratories must act now to remain competitive in an increasingly AI-driven healthcare landscape.

Following the recent CE IVDR certification for the Fusion AP platform, join us for this Pathology Bites interview, where we speak with Ben Cahoon, CEO of Techcyte, about achieving this certification.In this conversation, Ben explains what IVDR certification involves and why it represents a major regulatory shift from the previous IVDD framework. He discusses how stricter requirements, including notified body oversight and expanded clinical validation, are reshaping the landscape for digital pathology vendors and laboratories alike.The discussion also explores why regulatory approval is becoming a critical factor for adoption, giving laboratories the confidence to implement new technologies more efficiently. Ben shares how Fusion AP aims to support this transition, combining clinical and anatomic pathology in a single platform with integrated AI capabilities designed to improve workflow efficiency and diagnostic accuracy.The interview further examines the evolving role of AI in pathology, including the distinction between workflow-support tools and diagnostic algorithms, and how regulatory frameworks like IVDR will play a key role in ensuring innovation progresses alongside clinical trust.Finally, Ben looks ahead to Techcyte’s global expansion, including growth across Europe and ongoing efforts toward FDA clearance in the United States.

Following our recent article on the risks of shortcut learning in AI-driven cancer diagnostics, join us for this short Pathology News interview, where Sidney Ocanagil-Tunstall speaks with Dr. Fayyaz Minhas from the Tissue Image Analytics Centre (University of Warwick).In this brief conversation, Dr. Minhas expands on the key themes discussed in the article, exploring how AI models in pathology can achieve strong predictive performance while relying on correlations rather than true biological signals. He discusses challenges such as shortcut learning and confounding factors, and what this means for applications like predicting mutation status from whole slide images.The interview also touches on the importance of robust validation, thoughtful data design, and stronger collaboration between clinicians and computational scientists to ensure AI tools are safe, reliable, and truly beneficial for patient care.

Join us for this Pathology News podcast episode as Sidney Ocanagil-Tunstall speaks with Monika Lamba Saini about the growing impact of digital pathology, clinical trials, and AI, exploring how these technologies are reshaping workflows, biomarker discovery, and drug development.In this episode, Sidney speaks with Monika Lamba Saini, Global Translational Pathology Leader, who brings over 20 years of experience across clinical pathology, research, and clinical trials. She shares her perspective on the evolution of pathology from traditional microscopy to a more digital, data-driven discipline, highlighting how adoption accelerated during COVID-19 with the shift to remote slide review and virtual training.They discuss how digital pathology is improving clinical trials through centralized review, streamlined workflows, and enhanced global collaboration, while also reducing logistical challenges such as physical slide transport. Monika also explains how AI is transforming biomarker analysis, enabling more precise, reproducible, and scalable insights at cellular and subcellular levels, and supporting advances in translational research and drug development.Finally, the conversation looks ahead to the future of pathology, addressing ongoing challenges around validation, regulation, and data governance, while emphasizing a hybrid model where AI augments human expertise. Overall, the episode highlights a shift toward more efficient, collaborative, and patient-focused clinical trials driven by digital innovation.

In this Thought Leaders episode, Jonathon Tunstall, Founder and CEO of Pathology News, speaks with Martijn Hartjes, Global Business Unit Leader for Clinical Informatics at Philips. With more than 20 years at Philips spanning imaging, oncology, and informatics, Martijn shares his perspective on the evolution of digital diagnostics and the path toward large-scale adoption of digital pathology.They discuss why digital pathology adoption has been slower than expected despite advances in technology, and the real challenges laboratories face, from workflow redesign and change management to IT integration. Martijn also shares lessons learned from deploying digital pathology at scale across hundreds of laboratories worldwide.The conversation explores Philips’ enterprise approach to digital pathology, the importance of deep LIS integration and standards such as DICOM, and how pathology data is becoming an essential part of broader integrated diagnostics across radiology, oncology, and clinical informatics.Finally, they look ahead to the growing role of AI, cloud infrastructure, and enterprise imaging platforms in improving efficiency, addressing workforce shortages, expanding access to expertise, and enabling faster, more accurate diagnoses for patients worldwide.

Join us for this Thought Leaders episode as Dr Shan Raza, Associate Professor at the TIA Centre, University of Warwick, shares his journey from electrical engineering into computational pathology and AI-driven cancer research.Hosted by Sidney Ocanagil-Tunstall, Marketing Director of Pathology News, this conversation explores how Shan’s combined expertise in image analysis, wet lab workflows, and AI gives him a unique perspective on building robust algorithms for pathology.We discuss the growth and mission of the TIA Centre, the move toward multimodal analysis across pathology, radiology and genomics, and how international collaborations and grand challenges like CHIMERA are shaping the future of AI in medicine.A major focus of the episode is the TIA Toolbox, an open-source suite for running AI on pathology images, covering its motivation, core features, recent additions, and how it has supported multiple challenge wins across diverse tissue types.We also reflect on the realities of clinical AI deployment, trust, regulation, and why a human-in-the-loop approach will remain essential as digital pathology continues to evolve.This episode offers a practical and forward-looking view of how open tools, collaboration and multimodal data are driving the next phase of computational pathology.

Join us for this Thought Leaders episode as Prof. Saad Nadeem from Memorial Sloan Kettering Cancer Center explains how DeepLIIF and the DP4all (Digital Pathology for All) initiative are opening up new possibilities for digital pathology — from major cancer centres to small community labs and low-resource settings around the world.PresentersHosted by Jonathan Tunstall, CEO and Founder of Pathology News, this Thought Leaders episode features an exclusive interview with:Prof. Saad Nadeem, Computational Pathology & Medical Image Analysis, Memorial Sloan Kettering Cancer CenterIn this Thought Leaders conversation, we explore how Saad’s background in computer science, mathematics and medical image analysis led him from radiology into computational pathology, and why he views radiology, surgery and pathology as a single continuum along the patient journey.We discuss the development of DeepLIIF (Deep Learning Inferred Immunofluorescence) as a virtual re-stain method that can extend the dynamic range of IHC, improve cell and compartment segmentation, and provide a stronger foundation for robust biomarker quantification. Saad explains how this work underpins a broader push toward more objective, reproducible companion diagnostics.A major focus of the episode is DP4all, Mind’s “digital pathology for all” initiative, which uses a simple smartphone-plus-microscope workflow to generate shareable, cloud-hosted whole slide images without dedicated scanners or storage infrastructure. We examine how this approach can support telepathology, virtual tumour boards and second opinions in both low- and high-resource settings, and why many donated scanners in low-resource regions currently sit idle.We also touch on the CAP AI Playground collaboration with PathPresenter, designed to give pathologists transparent, hands-on access to AI tools without paywalls, and discuss the realities of regulation, validation and reimbursement for clinical deployment.With a frank discussion on whether digitisation is truly “inevitable,” and how accessible tools like DeepLIIF and DP4all could shift the economics and equity of digital pathology, this episode offers a compelling vision of how computational methods can support clinicians and patients far beyond the walls of major academic centres.

In this episode of Pathology News Talks, we sit down with Ben Cahoon, CEO of Techcyte, one of the most innovative leaders in the digital pathology space.Ben shares the journey from his early days at Intel to building Techcyte — a company redefining pathology through the Fusion Platform, which unites anatomic and clinical pathology in a single workflow.We dive into:💡 How Techcyte evolved from environmental and veterinary labs to human clinical and anatomic pathology🧬 The power of combining AI, workflow, and data integration🔬 The path to true multimodal pathology — merging digital slides, molecular data, and patient history⚙️ What “scanner agnostic” really means and why DICOM compliance is key🧠 Why the future of diagnostics isn’t AI versus humans, but AI with humansWhether you’re in pathology, informatics, or digital health, this one’s packed with insights on where our industry is heading and how software platforms like Fusion are accelerating that shift.

Captured live on 19th October 2025 at ESMO in Berlin, this Pathology News special with Felix Faber and Dr. Patrick Frey explores how multiplex immunofluorescence, paired with AI and foundation models, is enabling deeper insight into spatial biology, biomarker validation, and the evolving role of diagnostics in cancer care.For more on Mindpeak, head over to Pathology News.

In this episode of Pathology News Talks, we sit down with Andy Beck, Co-Founder and CEO of PathAI, to explore the transformation of pathology through artificial intelligence.Andy shares his journey from academia to building one of the most influential companies in digital pathology, reflects on the challenges of regulation and adoption, and discusses PathAI’s recent FDA clearance for its AISight DX platform. We also dive into collaborations with Roche and leading medical centres, the rise of digital biomarkers, and what the future of AI-powered pathology might look like in the next decade.If you want to understand how digital pathology, AI, and clinical workflows are converging to shape the future of diagnostics, this episode is for you.

Hosted by Jonathan Tunstall, CEO & Founder of Pathology News, this episode features: Katharina von Loga, Head of Pathology at Owkin.With a unique background in academic pathology and AI-driven diagnostics, Katharina shares how her journey from multiplex immunofluorescence to working with cutting-edge weakly supervised models shaped her perspective on the role of artificial intelligence in modern pathology.In this wide-ranging conversation, we explore: • Why AI is strengthening the business case for digital pathology • How Owkin’s models are uncovering novel biological insights • The path toward interpretability, regulatory trust, and integration in clinical workflows • Key products like the MSIntuit model for colorectal cancer and Owkin’s relapse prediction tools • The long-term vision for multimodal AI in pathology.We also touch on the State of the Nation and From Slide to Device white papers, offering insight into adoption trends, clinical barriers, and the future role of the pathologist.State of the Nation - https://www.owkin.com/connect/state-of-the-nationFrom Slide to Device - https://www.owkin.com/connect/slide-to-device📍 Don’t miss this deep dive into the evolving world of diagnostic AI and the future of digital pathology. 🔔 Like, comment, and subscribe for more episodes of Pathology Talks.#DigitalPathology #AIinHealthcare #Owkin #PathologyNews #MultimodalAI #MSIntuit

🎙️ Hosted by Jonathan Tunstall, CEO & Founder of Pathology News, this Thought Leaders episode features:🔹 Prasanth Perugupalli, Chief Product Officer at PramanaWith a background in electrical engineering and over 20 years of experience in imaging and product innovation, Prasanth shares how Pramana is reimagining digital pathology. From modular scanner architecture and built-in quality assurance to AI-powered, autonomous imaging, he lays out a clear vision for the future of pathology labs.We also explore the rise of digitally-native pathologists, the role of AI in diagnostic workflows, and how Pramana is gearing up for European expansion in 2025.📍 If you’re curious about the future of lab tech and smart imaging, this is a must-listen.🔔 Like, comment, and subscribe for more Pathology Talks: Thought Leaders episodes.#DigitalPathology #AIinHealthcare #Pramana #PathologyNews #ThoughtLeaders #LabInnovation

What happened in DP&AI in the last two weeks... let’s get into it!

🚀 Join us for an exclusive interview with Joe Yeh, Co-founder, CEO, and Chairman of aetherAI, as we explore how AI is revolutionizing digital pathology. From groundbreaking “True Gigapixel” technology to AI-powered diagnostics, Joe shares insights on industry challenges, regulatory hurdles, and the future of pathology.📍 Learn how aetherAI is integrating AI into pathology workflows, collaborating with global healthcare institutions, and pushing the boundaries of medical AI innovation.🔬 Don’t miss this deep dive into the future of digital pathology!📢 Catch aetherAI at USCAP 2025 (Booth 229) in Boston from March 22-27!🔔 Like, comment, and subscribe for more cutting-edge pathology news! #DigitalPathology #AIinHealthcare #PathologyNews

Meet our very own in-house AI podcasters, Ki and Mallory—bringing the latest in digital and computational pathology to you.

Join us as we dive into the world of digital pathology and explore how the revolutionary TWOD system is transforming the workflow for pathologists. Hosted by Sidney Ocanagil-Tunstall, Marketing Director at Pathology News, this episode features insightful discussions with: Dr. Jim Lu, Founder of DigitCells & GoPath DiagnosticsDr. Wojno, GU Pathology Expert and Early Digital Pathology AdopterJonathan Tunstall, CEO & Founder of Pathology News In this Thought Leaders episode we tackle the transition from traditional to digital pathology, the pain points in molecular sendouts, and how the TWOD system reduces inefficiencies while enhancing diagnostic accuracy. From reducing mouse clicks to optimizing tissue workflow, you don’t want to miss this deep dive into the future of pathology!